|
|
||||||||



* Division of Rheumatology, Childrens Hospital of Pittsburgh, University of Pittsburgh, School of Medicine, Pittsburgh, PA 15213;
Cincinnati Childrens Hospital Medical Center, Cincinnati, OH 45229;
Department of Cell Biology and Physiology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261;
Department of Epidemiology, Graduate School of Public Health, Pittsburgh, PA 15261; and
¶ Department of Molecular Genetics and Biochemistry, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261
While analyzing gene expression in collagen-induced arthritis, we discovered that a poorly characterized gene, follistatin-like protein 1 (FSTL-1), is highly overexpressed in mouse paws during early arthritis, especially at the interface of synovial pannus and eroding bone. In this study, we show that FSTL-1 is a novel proinflammatory molecule with a previously unrecognized role in inflammation. Transfection of FSTL-1 into macrophages and fibroblasts leads to up-regulation of proinflammatory cytokines, including IL-1
, TNF-
, and IL-6. Overexpression of FSTL-1 in mouse paws by gene transfer results in severe paw swelling and arthritis.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 This work was supported in part by National Institutes of Health Grants AI44566 (to R.H) and AI 56374 (to P.D.R).
2 Address correspondence and reprint requests to Dr. Raphael Hirsch, Division of Rheumatology, Childrens Hospital of Pittsburgh, 3705 Fifth Avenue, Pittsburgh, PA 15213. E-mail address: raphael.hirsch{at}chp.edu
3 Abbreviations used in this paper: FSTL-1, follistatin-like protein 1; RA, rheumatoid arthritis; CII, type II collagen; CIA, collagen-induced arthritis.
This article has been cited by other articles:
![]() |
S. D. Clutter, D. C. Wilson, A. D. Marinov, and R. Hirsch Follistatin-Like Protein 1 Promotes Arthritis by Up-Regulating IFN-{gamma} J. Immunol., January 1, 2009; 182(1): 234 - 239. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Lara-Pezzi, L. E. Felkin, E. J. Birks, P. Sarathchandra, K. D. Panse, R. George, J. L. Hall, M. H. Yacoub, N. Rosenthal, and P. J. R. Barton Expression of Follistatin-Related Genes Is Altered in Heart Failure Endocrinology, November 1, 2008; 149(11): 5822 - 5827. [Abstract] [Full Text] [PDF] |
||||
![]() |
D Ghosh, A M Sharkey, D S Charnock-Jones, S K Smith, and J. Sengupta Effect of low-dose mifepristone administration on day 2 after ovulation on transcript profiles in implantation-stage endometrium of rhesus monkeys Reproduction, August 1, 2008; 138(2): 357 - 370. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Dean, G. S. Butler, Y. Hamma-Kourbali, J. Delbe, D. R. Brigstock, J. Courty, and C. M. Overall Identification of Candidate Angiogenic Inhibitors Processed by Matrix Metalloproteinase 2 (MMP-2) in Cell-Based Proteomic Screens: Disruption of Vascular Endothelial Growth Factor (VEGF)/Heparin Affin Regulatory Peptide (Pleiotrophin) and VEGF/Connective Tissue Growth Factor Angiogenic Inhibitory Complexes by MMP-2 Proteolysis Mol. Cell. Biol., December 15, 2007; 27(24): 8454 - 8465. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |